<DOC>
	<DOCNO>NCT01175538</DOCNO>
	<brief_summary>To assess effect lactulose prevention first episode altered sensorium ( hepatic encephalopathy , primary prophylaxis ) patient cirrhosis .</brief_summary>
	<brief_title>Primary Prophylaxis Hepatic Encephalopathy Patients With Cirrhosis</brief_title>
	<detailed_description>Development hepatic encephalopathy patient cirrhosis associate poor survival rate 10-70 % one year depend upon hepatic renal function . Treating patient prevent development first episode hepatic encephalopathy classify primary prophylaxis hepatic encephalopathy prevent recurrence hepatic encephalopathy patient previous episode hepatic encephalopathy secondary prophylaxis hepatic encephalopathy</detailed_description>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>Lactulose</mesh_term>
	<criteria>cirrhotic patient ( 1870yrs ) never encephalopathy history take lactulose past 6 week alcohol intake past 6 week hepatocellular carcinoma previous TIPS shunt surgery significant co morbid illness heart , respiratory , renal failure neurologic diseases alzheimer 's disease , parkinson 's disease nonhepatic metabolic encephalopathy . patient psychoactive drug antidepressant sedative restart alcohol follow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Hepatic encephalopathy</keyword>
	<keyword>Lactulose</keyword>
</DOC>